Stephanie Hatch
Senior Research Scientist
Stephanie joined the HTS group in April 2016. She is responsible for developing and running high throughput screens, including ELISAs and various cellular phenotypic screens. Previously she performed cell-based assays as part of the Structural Genomic Consortium. She obtained her PhD from the University of North Carolina, Chapel Hill.
Recent publications
-
COVID-19 vaccination, risk-compensatory behaviours, and contacts in the UK.
Journal article
Buckell J. et al, (2023), Sci Rep, 13
-
Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK.
Journal article
Wei J. et al, (2023), Nat Commun, 14
-
Data from Targeting IGF Perturbs Global Replication through Ribonucleotide Reductase Dysfunction
Other
Rieunier G. et al, (2023)
-
Supplementary Data from Targeting IGF Perturbs Global Replication through Ribonucleotide Reductase Dysfunction
Other
Rieunier G. et al, (2023)
-
Supplementary Data from Targeting IGF Perturbs Global Replication through Ribonucleotide Reductase Dysfunction
Other
Rieunier G. et al, (2023)